DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants ...
Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), today announced the effective date of its 1-for-6.25 share consolidation (reverse stock split) of the Company's issued and ...
On a regional basis, Western Europe was the top portfolio contributor for quarter, with U.K. electric utility SSE and Spanish ...
Discover how below par bonds work, as they trade for less than their face value. Learn why bonds might trade at a discount due to market and economic conditions.
Discover how brokers are compensated in bond sales, the hidden transaction costs, and what it means for investors. Learn vital insights for better decision-making.
IRVINE, CA / / January 15, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today ...
ESTERO, FL / / January 14, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback